Factor VIII Dosing for Major Surgery in Hemophilia A
Preoperative Factor VIII Dosing
- The American Society of Hematology recommends target preoperative Factor VIII levels of 70-90 IU/dL for major surgery, with a dose calculation formula for patients ≥12 years: Dose (IU) = body weight (kg) × desired Factor VIII rise (IU/dL) × 0.5 3
- For children <12 years, the dose calculation formula is: Dose (IU) = body weight (kg) × desired Factor VIII rise (IU/dL) × 0.6 3
Postoperative Factor VIII Management
- The International Society on Thrombosis and Haemostasis (ISTH) suggests maintaining Factor VIII trough levels ≥50 IU/dL until wound healing is complete, with replacement therapy continued for 7-14 days total 3
Bolus vs. Continuous Infusion
- The ISTH Hemophilia Guideline Panel suggests either continuous or bolus infusion of Factor VIII concentrates for major surgery, as there is no important difference in efficacy 1, 2, 5
- Continuous infusion consumes approximately 30-40% less Factor VIII concentrate, which is relevant in resource-limited settings 5, 2
- Bolus infusion is the standard practice for Extended Half-Life (EHL) Factor VIII products, as continuous infusion is not validated for EHL 4, 1
Special Considerations
- For hemophilia A patients on emicizumab prophylaxis undergoing surgery, the European Hemophilia Consortium recommends using bolus infusions of Factor VIII, as this is the only approach with published safety data 4
- Surgery should only be performed at centers with requisite expertise in hemophilia management 4